Fibroblast-like synoviocyte (FLS)

Synoviocytes are cells that form the inner lining (intima) of the synovial membrane in joints. There are two major types: fibroblast-like synoviocytes (FLS), which produce components of synovial fluid (such as hyaluronan and lubricin) and mediate joint homeostasis; and macrophage-like synoviocytes, which are involved in clearance of debris and immune function[1][3][4][7]. FLS are essential for normal joint lubrication, nutrient supply to cartilage, and tissue integrity[3][5]. In disease states such as rheumatoid arthritis, FLS become abnormally activated and drive chronic inflammation, tissue destruction, and altered immune responses, making them a central pathological feature and an attractive—if challenging—therapeutic target[4][2][10]. No drugs currently target synoviocytes specifically, but several experimental approaches and disease-modifying drugs impact their activities indirectly[4][6][8].

Other names

Type B synoviocyteMacrophage-like synoviocyteSynovial lining cellIntimal synovial cell

Inhibition of inflammatory cytokine signaling (e.g., JAK/STAT pathway inhibition)[2][10]; Direct inhibition of cell proliferation or invasiveness of FLS (e.g., PTPRS)[8]; Blockade of matrix metalloproteinase production by FLS[4]